Literature DB >> 8937539

Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients.

S Helweg-Larsen1.   

Abstract

BACKGROUND: Despite many reports on metastatic spinal cord compression, only very few prospective studies of the clinical outcome of spinal cord compression have been carried out.
METHODS: 153 consecutive patients with a known malignant solid tumor and a myelographically verified diagnosis of spinal cord compression were followed with regular neurological examination.
RESULTS: At time of diagnosis 79 patients were walking, while the remaining were bedridden. In total 21 of the 74 initially non-walking patients began walking after therapy. There was a need for urinary catheter in 57 (37%) patients at the time of diagnosis. During follow-up, 10 of 57 patients (18%) dispensed with the catheter. A total of 116 patients experienced radicular pain at the time of diagnosis, while in 95 of 116 patients (83%) the pain disappeared after therapy.
CONCLUSION: the present study confirms, that early diagnosis, i.e., while the patients are still ambulatory, is most important, but the prognosis for recovery of ambulatory function is not as pessimistic as earlier described. In addition the results indicate that supplementary systemic therapy, when available, may have a positive influence on recovery.

Entities:  

Mesh:

Year:  1996        PMID: 8937539     DOI: 10.1111/j.1600-0404.1996.tb07064.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  24 in total

1.  Clinical profile of long-term survivors of breast or thyroid cancer with metastatic spinal tumours.

Authors:  Y Kasai; E Kawakita; A Uchida
Journal:  Int Orthop       Date:  2006-04-26       Impact factor: 3.075

2.  Radiosurgery for metastatic spinal tumors: follow-up MR findings.

Authors:  Y J Hwang; M-J Sohn; B H Lee; S Y Kim; J W Seo; Y H Han; J Y Lee; S J Cha; Y H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

3.  The timing of surgical intervention in the treatment of complete motor paralysis in patients with spinal metastasis.

Authors:  Yu Fan; Xi Zhou; Hai Wang; Pengxiang Jiang; Siyi Cai; Jianguo Zhang; Yong Liu
Journal:  Eur Spine J       Date:  2016-01-29       Impact factor: 3.134

4.  A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease.

Authors:  Paul Klimo; Clinton J Thompson; John R W Kestle; Meic H Schmidt
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

5.  Recurrent spinal epidural metastases: a prospective study with a complete follow up.

Authors:  J J van der Sande; W Boogerd; R Kröger; A C Kappelle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 6.  Metastasis to nervous system: spinal epidural and intramedullary metastases.

Authors:  Melike Mut; David Schiff; Mark E Shaffrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

7.  Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatment.

Authors:  F Kovner; S Spigel; I Rider; I Otremsky; I Ron; E Shohat; J M Rabey; J Avram; O Merimsky; N Wigler; S Chaitchik; M Inbar
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

8.  Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.

Authors:  Jiangtao Shen; Xinru Du; Lingxiu Zhao; Hui Luo; Ziyu Xu
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

Review 9.  Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.

Authors:  Carlo Greco; Oriol Pares; Nuno Pimentel; Elizabeth Moser; Vasco Louro; Xavier Morales; Barbara Salas; Zvi Fuks
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-18

Review 10.  Spinal radiosurgery: technology and clinical outcomes.

Authors:  M Avanzo; P Romanelli
Journal:  Neurosurg Rev       Date:  2008-09-24       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.